Skip to main content

ZURICH HEART HOUSE

The Zurich Heart House creates and communicates new knowledge in the field of cardiovascular diseases. Through its affiliation with the University of Zurich, the editorial mandate of the "European Heart Journal" and as the seat of the "Foundation for Cardiovascular Research", the Zurich Heart House is one of the most important cardiology research and education centres in Europe.

The Zurich Heart House is a place of creative knowledge exchange between researchers, scientists, clinicians, practicing physicians, lecturers and staff. As a think tank, it is intended to strengthen Zurich as a location and serve as a service centre for doctors and patients with cardiovascular diseases.

Stay up to date with all our events - subscribe to our Newsletter HERE!


Annual Report 2023*

*in German

ZHH News

Prevention Summit 2024

Prevention Summit Berlin 2024 | Die Videos sind jetzt GRATIS online verfügbar

Die Vorträge von erfahrenen und prominenten Rednern umfassen wichtige Aspekte der kardiovaskulären Prävention und Risikoerfassung.

Lassen Sie sich diese Gelegenheit nicht entgehen und schauen Sie sich die Videoaufzeichnungen HIER gratis an!

TFL

Prof. Thomas F. Lüscher receives Honorary Membership

Professor Thomas F. Lüscher receives a honorary membership from the Romanian Society of Cardiology.

Congratulation!

Cardiology News

ESC Board

European Society of Cardiology Board 2024-2026

The ESC Board 2024 - 2026 under the presidency of Prof. Thomas F. Lüscher.

Learn more here!

AI-Cardiology

The cardiologist in the age of artificial intelligence: what is left for us?

No doubt, AI will transform cardiology as it is a specialty integrating vast amounts of data on patient history, symptoms, ECGs, laboratory values, and imaging of all sorts. So, what is left for the physician?

Read full article (Cardiovascular Research (2024) 00, 1–3)

Sex-Shock

Sex-specific prediction of cardiogenic shock after acute coronary syndromes: the SEX-SHOCK score

Cardiogenic shock (CS) remains the primary cause of in-hospital death after acute coronary syndromes (ACS), with its plateauing mortality rates approaching 50%. However, its sex-specific performance remains unknown, and refined risk prediction strategies are warranted.

Read full article (European Heart Journal (2024) 00, 1–15)